Fulminant subacute sclerosing panencephalitis in an immunized 20-month-old Indian boy
=====================================================================================

* Mahmood D. Al-Mendalawi

*To the Editor*

I have read the interesting case report by Khursheed et al,1 published in October 2018’s issue of Neurosciences (Riyadh). The authors nicely described a case of fulminant subacute sclerosing panencephalitis (SSPE) in a 20-month-old Indian patient who was fully vaccinated for measles.1 I have 2 comments on it.

First, I agree with the authors’ presumption that it was difficult to attribute the diagnosis of SSPE in the studied patient to the vaccination received at 9 months and 16 months of age and that the possibility of subclinical measles infection probably overlooked by parents is most likely.1 However, they didn’t attempt to support their presumption. I presume that the following point might be relevant. It is noteworthy that anecdotal studies on the molecular characterization of the entire coding region of measles virus (MV) isolated from SSPE cases have shown certain biased hypermutations in certain sequences related to different genes, including M, H, N, F and D4. These hypermutations are known to play an important role in the glycoprotein interaction and to hamper the ability of measles virus strain to produce cell-free infectious viral particles, and ultimately incorporated in the maintenance of persistent infection, disease development, and fulminant escalation.2-5 Moreover, no genome sequences of measles vaccine strains were detected from SSPE cases.2-5 I presume that a similar molecular characterization of the whole genome of MV in the studied patient was envisaged. I presume that the task could not be contemplated probably due to financial constraints. Despite that limitation, the authors sent a sound message to the practicing pediatricians that SSPE must be considered in any child with mental and neurological deficits regardless of prior immunization for measles.

Second, it is worthy to mention that early age exposure to measles predisposes to the development of SSPE and this risk is accentuated in human immunodeficiency virus (HIV)-positive children. The recent succession of measles outbreaks due to virus introduction in the pediatric population with suboptimal vaccine coverage or reducing immunity and co-existing pediatric HIV cohorts represents a matter of concern.6 I presume that underlying HIV infection could contribute to the fulminating clinical course in the studied patient. HIV infection is an important health threat in India. Despite no recent data are yet presented on the exact pediatric HIV seroprevalence, the available data pointed out to the substantial HIV seroprevalence rate of 1.03% among pregnant women in India.7 Regrettably, the HIV status of the mother of the studied patient was not defined. I presume that some sort of vertical HIV transmission ought to be taken into consideration in the studied patient. Therefore, planning for the diagnostic panel of blood CD4 lymphocyte count and viral overload estimations was envisaged in the studied patient. If that panel was contemplated and it disclosed HIV reactivity, the case in question could be truly regarded a novel case report of the youngest patient with HIV-associated SSPE published in the literature to date.

*Reply from the Author*

I thank Prof. Al-Mendalawi for his invaluable comments on our article published in October’s issue of Neurosciences (Riyadh).1 The 2 concerns raised by the author are valid and could have been incorporated in the discussion section of the report. In a study on characterization of measles virus strains in patients with SSPE, it was observed that none of the vaccine strain sequences were detected among those who were vaccinated.2 Owing to financial constraints and nonavailability of this facility, the molecular characterization of measles virus could not be performed. We acknowledge this as a limitation of the present work-up. However, we believe molecular characterization in the present case could probably address the concern to what caused SSPE in this vaccinated child; Is it vaccine strain or some subclinical wild-type infection?. Irrespective of the reply, we would still defend the message to consider the clinical possibility of SSPE based on a cluster of symptoms and signs regardless of vaccination status. A vaccinated child can acquire subclinical wild virus infection considering suboptimal coverage, and variable rates of seroprotection following measles vaccination in Indian children.8 To address the second valid concern, the index case, as well as their both parents, had tested negative for HIV. In developing countries like India, HIV is always on the top of clinical differentials for neuroregression in infants and young children. Hence, clinical findings in the reported case need to be interpreted in the context of lack of molecular characterization in the work-up.

*Jaya S. Kaushik*

*Department of Pediatrics Pandit Bhagwat Dayal Sharma Postgraduate Institute of Medical Sciences, Rohtak, Haryana, India*

Supplements

* Supplements will be considered for work including proceedings of conferences or subject matter covering an important topic

* Material can be in the form of original work or abstracts.

* Material in supplements will be for the purpose of teaching rather than research.

* The Guest Editor will ensure that the financial cost of production of the supplement is covered.

* Supplements will be distributed with the regular issue of the journal but further copies can be ordered upon request.

* Material will be made available on Saudi Medical Journal website

*   Copyright: © Neurosciences

Neurosciences is an Open Access journal and articles published are distributed under the terms of the Creative Commons Attribution-NonCommercial License (CC BY-NC). Readers may copy, distribute, and display the work for non-commercial purposes with the proper citation of the original work.

## References

1.  Khursheed A, Hota D, Bhalla K, Kaushik JS (2018) Fulminant subacute sclerosing panencephalitis in an immunized 20-month-old Indian boy. Neurosciences (Riyadh) 23, 351–353.
    
    

2.  Jin L, Beard S, Hunjan R, Brown DW, Miller E (2002) Characterization of measles virus strains causing SSPE:a study of 11 cases. J Neurovirol 8, 335–344.
    
    

3.  Forcić D, Baricević M, Zgorelec R, Kruzić V, Kaić B, Marina BM, et al. (2004) Detection and characterization of measles virus strains in cases of subacute sclerosing panencephalitis in Croatia. Virus Res 99, 51–56.
    
    

4.  Moulin E, Beal V, Jeantet D, Horvat B, Wild TF, Waku-Kouomou D (2011) Molecular characterization of measles virus strains causing subacute sclerosing panencephalitis in France in 1977 and 2007. J Med Virol 83, 1614–1623.
    
    

5.  Ivancic-Jelecki J, Baricevic M, Santak M, Harcet M, Tešović G, Marusic Della Marina B, et al. (2013) The first genetic characterization of a D4 measles virus strain derived from a patient with subacute sclerosing panencephalitis. Infect Genet Evol 17, 71–78.
    
    

6.  Manesh A, Moorthy M, Bandopadhyay R, Rupali P (2017) HIV-associated sub-acute sclerosing panencephalitis - an emerging threat? Int J STD AIDS 28, 937–939.
    
    

7.  Sibia P, Mohi MK, Kumar A (2016) Seroprevalence of Human Immunodeficiency Virus Among Antenatal Women in One of the Institute of Northern India. J Clin Diagn Res 10, QC08–QC09.
    
    

8.  Awofeso N, Rammohan A, Iqbal K (2013) Age-appropriate vaccination against measles and DPT-3 in India - closing the gaps. BMC Public Health 13, 358.